Recent developments in the discovery of MCH-1R antagonist for the treatment of obesity - An update

Expert Opinion on Therapeutic Patents

Volumn 15, Issue 10, 2005, Pages 1303-1313

  Dyke, Hazel J ^b   Ray, Nicholas C ^a  

^a Argenta Discovery Ltd   (United Kingdom)

^b NONE

Author keywords

MCH receptor; MCH 1R; Melanin concentrating hormone (MCH); Obesity

Indexed keywords

2 AMINOTETRALIN DERIVATIVE; 856464; AMG 076; AMIDE; AMINOQUINOLINE DERIVATIVE; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; CARBAZOLE DERIVATIVE; CYCLOPEPTIDE; IMIDAZOPYRIDINE DERIVATIVE; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE 1 RECEPTOR BLOCKING AGENT; N (6 DIMETHYLAMINOMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYL) 4' FLUORO 1,1' BIPHENYL 4 CARBOXAMIDE; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; PIPERIDINE; PIPERIDINE DERIVATIVE; PYRIMIDINONE DERIVATIVE; QUINAZOLINE DERIVATIVE; QUINOLINE DERIVATIVE; SIBUTRAMINE; SNAP 7941; TETRAHYDROISOQUINOLINE DERIVATIVE; TETRAHYDROLIPSTATIN; TETRAHYDROQUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; UREA; UREA DERIVATIVE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG STRUCTURE; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; NONHUMAN; OBESITY; REGULATORY MECHANISM; REVIEW; RODENT; SIDE EFFECT;

EID: 27744548616     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.15.10.1303     Document Type: Review

References (24)

1. FLEGAL K, CARROLL MS, OGDEN CL, JOHNSON CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 288:1723-1727.
2. KOPELMAN PG: Obesity as a medical problem. Nature (2000) 404:635-643.
3. GURA T: Obesity drug pipeline not so fat. Science (2003) 299:849-852.
4. BROWNING A: Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agents. Expert Opin. Ther. Patents (2004) 14:313-325.
5. KOWALSKI TJ, McBRIAR MD: Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity. Expert Opin. Investig. Drugs (2004) 13:1113-1122.
6. CARPENTER AJ, HERTZOG DL: Melanin-concentrating hormone receptor antagonists as potential antiobesity agents. Expert Opin. Ther. Patents (2002) 12:1639-1646.
7. BOUTIN JA, SUPLY T, AUDINOT V et al.: Melanin-concentrating hormone and its receptors: state of the art. Can. J. Physiol. Pharmacol. (2002) 80:388-385.
8. HERVIEU G: Melanin-concentrating hormone functions in the nervous system: food intake and stress. Expert Opin. Ther. Targets (2003) 7:495-511.
9. QU D, LUDWIG DS, GAMMELTOFT S et al.: a role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (1996) 380:243.
10. SHIMADA M, TRITOS NA, LOWELL BB, FLIER JS, MARATOS-FLIER E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 396:670-674.
11. LUDWIG DS, TRITOS NA, MASTAITIS JW et al.: Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J. Clin. Investig. (2001) 107:379-386.
12. CHEN Y, HU C, HSU C-K et al.: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 143:2469-2477.
13. COLLINS AC, KYM PR: Prospects for obesity treatment: MCH receptor antagonists. Curr. Opin. Investig. Drugs (2003) 4:386.
14. TAKEKAWA S, ASAMI A, ISHIHARA Y et al.: T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur. J. Pharmacol. (2002) 438:129.
15. BOROWSKY B, DURKIN MM, OGOZALEK K et al.: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. (2002) 8:779-781.
16. SOUERS AJ, GAO J, WODKA D et al.: Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor-1 antagonists for the treatment of obesity. Bioorg. Med. Chem. Lett. (2005) 15:2752-2757.
17. SOUERS A J, GAO J, BRUNE M et al.: Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor-1 antagonist for the treatment of obesity. J. Med. Chem. (2005) 48:1318-1321.
18. MCBRIAR M D, GUZIK H, XU R et al.: Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics. J. Med. Chem. (2005) 48:2274-2277.
19. Thomson Current Drugs: drug report for AMG-076.
20. Thomson Current Drugs: drug report for 856464.
21. SOUERS AJ, WODKA D, GAO J et al.: Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCH-1R antagonists. Part 1. Bioorg. Med. Chem. Lett. (2004) 14:4873-4877.
22. VASUDEVAN A, WODKA D, VERZAL MK et al.: Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCH-1R antagonists. Part 2. Bioorg. Med. Chem. Lett. (2004) 14:4879-4882.
23. SOUERS AJ, WODKA D, GAO J et al.: Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCH-1R antagonists. Part 3. Bioorg. Med. Chem. Lett. (2004) 14:4883-4886.
24. GREY J, DYCK B, ROWBOTTOM MW et al.: Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists. Bioorg. Med. Chem. Lett. (2005) 15:999-1004.